{
  "id": 461709,
  "title": "Curium acquires Abscint SA, expanding PET radiodiagnostic pipeline in oncology",
  "url": "https://urgent.news/2026/08/10/curium-acquires-abscint-sa-expanding-pet-radiodiagnostic-pipeline-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-10T11:05:12.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/curium-acquires-abscint-sa-expanding-pet-radiodiagnostic-pipeline-in-oncology"
  },
  "original_language": "en",
  "account": null,
  "summary": "Acquisition adds ABS-011, an investigational Phase 2b gallium-68-labeled PET radiodiagnostic tracer targeting HER2 Transaction strengthens Curium radiodiagnostic capabilities and oncology footprint, including in breast and gastric cancers BOSTON and LIEGE, Belgium, Aug. 10, 2026 (GLOBE NEWSWIRE) — Curium™ a leading global radiopharmaceutical company, announced that it has completed the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}